2139261-06-4
Chemical Structure
SG3376
- CAS. Nr.: 2139261-06-4
- Formula:C57H63N7O14
- Molecular Weight:1070.15
InChIKey: PIFDLAJNQIABOU-MJPWBCPGSA-N
SMILES: O=C1C2=CC(OC)=C(OCC3=CC(COC4=C(C=C5C(N=C[C@@]6([H])N(C=C(C6)C)C5=O)=C4)OC)=CC(C#CCNC(CCOCCOCCOCCOCCNC(CCN7C(C=CC7=O)=O)=O)=O)=C3)C=C2N=C[C@@]8([H])N1C=C(C8)C
Biological Activity: SG3376 is an antibody-drug conjugate (ADC) targeting human epidermal growth factor receptor 2 (HER2). SG3376 is promising for research of HER2-overexpressing cancers (e.g., breast, gastric cancer)[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
SG3376 | SG3376 is an antibody-drug conjugate (ADC) targeting human epidermal growth factor receptor 2 (HER2). SG3376 is promising for research of HER2-overexpressing cancers (e.g., breast, gastric cancer). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords